Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Ferrari, S; Bertoni, F; Mercuri, M; Sottili, S; Versari, M; Bacci, G
   Ewing's sarcoma of bone: Relation between clinical characteristics and staging
   ONCOLOGY REPORTS
   
   S. Ferrari et al., "Ewing's sarcoma of bone: Relation between clinical characteristics and staging", ONCOL REP, 8(3), 2001, pp. 553-556
2. Bazzoli, F; Cecchini, L; Corvaglia, L; Dall'Antonia, M; De Giacomo, C; Fossi, S; Casali, LG; Gullini, S; Lazzari, R; Leggeri, G; Lerro, P; Valdambrini, V; Mandrioli, G; Marani, M; Martelli, P; Miano, A; Nicolini, G; Oderda, G; Pazzi, P; Pozzato, P; Ricciardiello, L; Roda, E; Simoni, P; Sottili, S; Torre, G; Urso, L; Zagari, RM
   Validation of the C-13-urea breath test for the diagnosis of Helicobacter pylori infection in children: A multicenter study
   AMERICAN JOURNAL OF GASTROENTEROLOGY
   
   F. Bazzoli et al., "Validation of the C-13-urea breath test for the diagnosis of Helicobacter pylori infection in children: A multicenter study", AM J GASTRO, 95(3), 2000, pp. 646-650
3. Serra, M; Maurici, D; Scotlandi, K; Barbanti-Brodano, G; Manara, MC; Benini, S; Picci, P; Bertoni, F; Bacci, G; Sottili, S; Baldini, N
   Relationship between P-glycoprotein expression and p53 status in high-grade osteosarcoma
   INTERNATIONAL JOURNAL OF ONCOLOGY
   
   M. Serra et al., "Relationship between P-glycoprotein expression and p53 status in high-grade osteosarcoma", INT J ONCOL, 14(2), 1999, pp. 301-307
4. Baldini, N; Scotlandi, K; Serra, M; Picci, P; Bacci, G; Sottili, S; Campanacci, M
   P-glycoprotein expression in osteosarcoma: A basis for risk-adapted adjuvant chemotherapy
   JOURNAL OF ORTHOPAEDIC RESEARCH
   
   N. Baldini et al., "P-glycoprotein expression in osteosarcoma: A basis for risk-adapted adjuvant chemotherapy", J ORTHOP R, 17(5), 1999, pp. 629-632
5. Festi, D; Sottili, S; Colecchia, A; Attili, A; Mazzella, G; Roda, E; Romano, F
   Clinical manifestations of gallstone disease: Evidence from the multicenter Italian study on cholelithiasis (MICOL)
   HEPATOLOGY
   
   D. Festi et al., "Clinical manifestations of gallstone disease: Evidence from the multicenter Italian study on cholelithiasis (MICOL)", HEPATOLOGY, 30(4), 1999, pp. 839-846
6. FESTI D; COLECCHIA A; ORSINI M; SANGERMANO A; SOTTILI S; SIMONI P; MAZZELLA G; VILLANOVA N; BAZZOLI F; LAPENNA D; PETRONI ML; PAVESI S; NERI M; RODA E
   GALLBLADDER MOTILITY AND GALLSTONE FORMATION IN OBESE PATIENTS FOLLOWING VERY-LOW-CALORIE DIETS - USE IT (FAT) TO LOSE IT (WELL)
   International journal of obesity
   
   D. Festi et al., "GALLBLADDER MOTILITY AND GALLSTONE FORMATION IN OBESE PATIENTS FOLLOWING VERY-LOW-CALORIE DIETS - USE IT (FAT) TO LOSE IT (WELL)", International journal of obesity, 22(6), 1998, pp. 592-600
7. JABOLI F; FABBRI C; MAZZELLA G; CIPOLLA A; SOTTILI S; ZAMBONIN L; RODA E
   C-13-PHENYLALANINE AND C-13-AMINOPYRINE BREATH TESTS FOR THE ASSESSMENT OF HEPATIC-DISEASE SEVERITY
   Hepatology
   
   F. Jaboli et al., "C-13-PHENYLALANINE AND C-13-AMINOPYRINE BREATH TESTS FOR THE ASSESSMENT OF HEPATIC-DISEASE SEVERITY", Hepatology, 28(4), 1998, pp. 1778-1778
8. FABBRI C; JABOLI MF; MAZZELLA G; SOTTILI S; MARCHETTO S; PEZZOLI A; ECCOGLI E; RODA E
   GASTRIC AUTOIMMUNE DISORDERS IN PATIENTS WITH CHRONIC HEPATITIS-C BEFORE, DURING AND POST INTERFERON-ALPHA THERAPY
   Hepatology
   
   C. Fabbri et al., "GASTRIC AUTOIMMUNE DISORDERS IN PATIENTS WITH CHRONIC HEPATITIS-C BEFORE, DURING AND POST INTERFERON-ALPHA THERAPY", Hepatology, 28(4), 1998, pp. 2189-2189
9. BAZZOLI F; ZAGARI M; POZZATO P; VAROLI O; FOSSI S; RICCIARDIELLO L; ALAMPI G; NICOLINI G; SOTTILI S; SIMONI P; RODA A; RODA E
   EVALUATION OF SHORT-TERM LOW-DOSE TRIPLE THERAPY FOR THE ERADICATION OF HELICOBACTER-PYLORI BY FACTORIAL DESIGN IN A RANDOMIZED, DOUBLE-BLIND, CONTROLLED-STUDY
   Alimentary pharmacology & therapeutics
   
   F. Bazzoli et al., "EVALUATION OF SHORT-TERM LOW-DOSE TRIPLE THERAPY FOR THE ERADICATION OF HELICOBACTER-PYLORI BY FACTORIAL DESIGN IN A RANDOMIZED, DOUBLE-BLIND, CONTROLLED-STUDY", Alimentary pharmacology & therapeutics, 12(5), 1998, pp. 439-445
10. ACCOGLI E; TRERE D; MAZZELLA G; COLECCHIA A; SOTTILI S; CASANOVA S; MARCHETTO S; FABBRI C; JABOLI F; FESTI D; RODA E; DERENZINI M
    THE SEVERITY OF HCV-RELATED CHRONIC HEPATITIS CORRELATES WITH AGNOR PROTEIN EXPRESSION WHILE RESPONSE TO ALPHA-INTERFERON TREATMENT IS ASSOCIATED WITH ITS DECREASE
    Gastroenterology
    
    E. Accogli et al., "THE SEVERITY OF HCV-RELATED CHRONIC HEPATITIS CORRELATES WITH AGNOR PROTEIN EXPRESSION WHILE RESPONSE TO ALPHA-INTERFERON TREATMENT IS ASSOCIATED WITH ITS DECREASE", Gastroenterology, 114(4), 1998, pp. 3-3
11. FABBRI C; JABOLI MF; MAZZELLA G; SOTTILI S; MARCHETTO S; PEZZOLI A; ACCOGLI E; RODA E
    GASTRIC AUTOIMMUNE DISORDERS IN PATIENTS WITH CHRONIC HEPATITIS-C BEFORE, DURING AND POST INTERFERON-ALPHA THERAPY
    Gastroenterology
    
    C. Fabbri et al., "GASTRIC AUTOIMMUNE DISORDERS IN PATIENTS WITH CHRONIC HEPATITIS-C BEFORE, DURING AND POST INTERFERON-ALPHA THERAPY", Gastroenterology, 114(4), 1998, pp. 164-164
12. BAZZOLI F; ZAGARI RM; PALLI D; FESTI D; POZZATO P; MASALA G; SOTTILI S; PANUCCIO D; RICCIARDIELLO L; NICOLINI G; FOSSI S; EDILI E; SIMONI P; RODA A; RODA E
    A POPULATION-BASED STUDY OF HELICOBACTER-PYLORI INFECTION - IV - PREVALENCE BY C-13-UREA BREATH TEST AND NUMBER OF SIBLINGS
    Gastroenterology
    
    F. Bazzoli et al., "A POPULATION-BASED STUDY OF HELICOBACTER-PYLORI INFECTION - IV - PREVALENCE BY C-13-UREA BREATH TEST AND NUMBER OF SIBLINGS", Gastroenterology, 114(4), 1998, pp. 279-279
13. BAZZOLI F; ZAGARI RM; PALLI D; FESTI D; POZZATO P; MASALA G; SOTTILI S; PANUCCIO D; RICCIARDIELLO L; NICOLINI G; FOSSI S; EDILI E; SIMONI P; RODA A; RODA E
    A POPULATION-BASED STUDY OF HELICOBACTER-PYLORI INFECTION - V - EXCESS DELTA(CO2)-C-13 EXCRETION AS AN INDICATOR OF BACTERIAL LOAD IS ASSOCIATED WITH DEMOGRAPHIC AND INDIVIDUAL FACTORS
    Gastroenterology
    
    F. Bazzoli et al., "A POPULATION-BASED STUDY OF HELICOBACTER-PYLORI INFECTION - V - EXCESS DELTA(CO2)-C-13 EXCRETION AS AN INDICATOR OF BACTERIAL LOAD IS ASSOCIATED WITH DEMOGRAPHIC AND INDIVIDUAL FACTORS", Gastroenterology, 114(4), 1998, pp. 280-280
14. ZAGARI RM; POZZATO P; BAZZOLI F; FOSSI S; RICCIARDIELLO L; NICOLINI G; BERETTI D; DELUCA L; ALAMPI G; SALFI N; MARTINELLI G; SOTTILI S; FESTI D; NERI M; SIMONI P; RODA A; RODA E
    A COMPARATIVE TRIAL TO OPTIMIZE THE PROTOCOL OF THE C-13 UREA BREATH TEST FOR THE DIAGNOSIS OF HELICOBACTER-PYLORI INFECTION
    Gastroenterology
    
    R.M. Zagari et al., "A COMPARATIVE TRIAL TO OPTIMIZE THE PROTOCOL OF THE C-13 UREA BREATH TEST FOR THE DIAGNOSIS OF HELICOBACTER-PYLORI INFECTION", Gastroenterology, 114(4), 1998, pp. 1403-1403
15. COLECCHIA A; ORSINI M; ANGELUCCI R; LAROCCA A; SOTTILI S; VILLANOVA N; MAZZELLA G; AMENTA E; PARADISO D; CARIANI S; RODA E; FESTI D
    GALLSTONE FORMATION AFTER VERTICAL BANDED GASTROPLASTY FOR MORBID-OBESITY - INCIDENCE, RISK-FACTORS AND ROLE OF GALLBLADDER MOTILITY
    Gastroenterology
    
    A. Colecchia et al., "GALLSTONE FORMATION AFTER VERTICAL BANDED GASTROPLASTY FOR MORBID-OBESITY - INCIDENCE, RISK-FACTORS AND ROLE OF GALLBLADDER MOTILITY", Gastroenterology, 114(4), 1998, pp. 2112-2112
16. TUCCI A; POLI L; PAPARO GF; BOCUS P; TOGLIANI T; MAZZONI C; ORCIONI GF; AGOSTI R; GRIGIONI WF; SOTTILI S; CALETTI G
    WEEKEND THERAPY FOR THE TREATMENT OF HELICOBACTER-PYLORI INFECTION
    The American journal of gastroenterology
    
    A. Tucci et al., "WEEKEND THERAPY FOR THE TREATMENT OF HELICOBACTER-PYLORI INFECTION", The American journal of gastroenterology, 93(5), 1998, pp. 737-742
17. BACCI G; FERRARI S; BERTONI F; MERCURI M; FORNI C; SOTTILI S; GASBARRINI A; TIENGHI A; CESARI M; CAMPANACCI M
    NEOADJUVANT CHEMOTHERAPY FOR OSSEOUS MALIGNANT FIBROUS HISTIOCYTOMA OF THE EXTREMITY - RESULTS IN 18 CASES AND COMPARISON WITH 112 CONTEMPORARY OSTEOSARCOMA PATIENTS TREATED WITH THE SAME CHEMOTHERAPY REGIMEN
    Journal of chemotherapy
    
    G. Bacci et al., "NEOADJUVANT CHEMOTHERAPY FOR OSSEOUS MALIGNANT FIBROUS HISTIOCYTOMA OF THE EXTREMITY - RESULTS IN 18 CASES AND COMPARISON WITH 112 CONTEMPORARY OSTEOSARCOMA PATIENTS TREATED WITH THE SAME CHEMOTHERAPY REGIMEN", Journal of chemotherapy, 9(4), 1997, pp. 293-299
18. ACCOGLI E; TRERE D; MAZZELLA G; COLECCHIA A; SOTTILI S; CASANOVA S; MARCHETTO S; FABBRI C; JABOLI F; FESTI D; RODA E; DERENZINI M
    THE SEVERITY OF HCV-RELATED CHRONIC HEPATITIS CORRELATES WITH AGNOR PROTEIN EXPRESSION WHILE RESPONSE TO IFN TREATMENT IS ASSOCIATED WITH ITS DECREASE
    Hepatology
    
    E. Accogli et al., "THE SEVERITY OF HCV-RELATED CHRONIC HEPATITIS CORRELATES WITH AGNOR PROTEIN EXPRESSION WHILE RESPONSE TO IFN TREATMENT IS ASSOCIATED WITH ITS DECREASE", Hepatology, 26(4), 1997, pp. 722-722
19. AZZAROLI F; MAZZELLA G; DEVERGORI E; FESTI D; COLECCHIA A; VILLANOVA N; SIMONI P; MAZZEO C; SOTTILI S; RODA E
    SLUGGISH GALLBLADDER AND SMALL-BOWEL MOTILITY ARE ASSOCIATED WITH CHOLESTEROL GALLSTONES
    Gut
    
    F. Azzaroli et al., "SLUGGISH GALLBLADDER AND SMALL-BOWEL MOTILITY ARE ASSOCIATED WITH CHOLESTEROL GALLSTONES", Gut, 41, 1997, pp. 32-32
20. BAZZOLI F; ZAGARI RM; FESTI D; PALLI D; POZZATO P; SOTTILI S; PANNUCCIO D; RICCIARDIELLO L; NICOLINI G; FOSSI S; COLECCHIA A; SIMONI P; RODA A; RODA E
    A POPULATION-BASED STUDY OF HELICOBACTER-PYLORI INFECTION .1. PREVALENCE BY C-13-UREA BREATH TEST AND ASSOCIATION WITH SOCIODEMOGRAPHIC FACTORS
    Gut
    
    F. Bazzoli et al., "A POPULATION-BASED STUDY OF HELICOBACTER-PYLORI INFECTION .1. PREVALENCE BY C-13-UREA BREATH TEST AND ASSOCIATION WITH SOCIODEMOGRAPHIC FACTORS", Gut, 41, 1997, pp. 106-106
21. BAZZOLI F; ZAGARI RM; FESTI D; PALLI D; POZZATO P; SOTTILI S; PANNUCCIO D; RICCIARDIELLO L; NICOLINI G; FOSSI S; SIMONI P; RODA A; RODA E
    A POPULATION-BASED STUDY OF HELICOBACTER-PYLORI INFECTION .2. UPREVALENCE BY C-13-UREA BREATH TEST AND ASSOCIATION WITH FAMILY HISTORY OF PEPTIC-ULCER AND GASTRIC-CANCER
    Gut
    
    F. Bazzoli et al., "A POPULATION-BASED STUDY OF HELICOBACTER-PYLORI INFECTION .2. UPREVALENCE BY C-13-UREA BREATH TEST AND ASSOCIATION WITH FAMILY HISTORY OF PEPTIC-ULCER AND GASTRIC-CANCER", Gut, 41, 1997, pp. 106-106
22. BAZZOLI F; ZAGARI RM; FESTI D; PALLI D; POZZATO P; SOTTILI S; PANNUCCIO D; RICCIARDIELLO L; NICOLINI G; FOSSI S; COLECCHIA A; SIMONI P; RODA A; RODA E
    A POPULATION-BASED STUDY OF HELICOBACTER-PYLORI INFECTION .3. PREVALENCE BY C-13-UREA BREATH TEST AND ASSOCIATION WITH DYSPEPTIC SYMPTOMS
    Gut
    
    F. Bazzoli et al., "A POPULATION-BASED STUDY OF HELICOBACTER-PYLORI INFECTION .3. PREVALENCE BY C-13-UREA BREATH TEST AND ASSOCIATION WITH DYSPEPTIC SYMPTOMS", Gut, 41, 1997, pp. 106-106
23. FABBRI C; MAZZELLA G; MARCHETTO S; PEZZOLI A; ACCOGLI E; FUSAROLI P; AZZAROLI F; MAZZEO C; JABOLI F; SOTTILI S; RODA E
    EFFICACY OF URSODEOXYCHOLIC ACID ADMINISTRATION AS ADJUVANT THERAPY TOGETHER WITH ALFA-INTERFERON FOR CHRONIC HEPATITIS-C
    Gut
    
    C. Fabbri et al., "EFFICACY OF URSODEOXYCHOLIC ACID ADMINISTRATION AS ADJUVANT THERAPY TOGETHER WITH ALFA-INTERFERON FOR CHRONIC HEPATITIS-C", Gut, 41, 1997, pp. 131-131
24. ACCOGLI E; MAZZELLA G; SOTTILI S; COLECCHIA A; FESTI D; JABOLI F; CIRIACI AM; RODA E
    ALPHA-INTERFERON PREVENTS HEPATOCELLULAR-CARCINOMA IN RESPONDERS WITHHCV-ASSOCIATED HEPATIC CIRRHOSIS
    Gut
    
    E. Accogli et al., "ALPHA-INTERFERON PREVENTS HEPATOCELLULAR-CARCINOMA IN RESPONDERS WITHHCV-ASSOCIATED HEPATIC CIRRHOSIS", Gut, 41, 1997, pp. 133-133
25. JABOLI F; FABBRI C; MAZZELLA G; CIPOLLA A; SOTTILI S; ZAMBONIN L; RODA E
    C-13-PHENYLALANINE AND C-13-AMINOPYRINE BREATH TESTS FOR THE ASSESSMENT OF HEPATIC-DISEASE SEVERITY
    Gut
    
    F. Jaboli et al., "C-13-PHENYLALANINE AND C-13-AMINOPYRINE BREATH TESTS FOR THE ASSESSMENT OF HEPATIC-DISEASE SEVERITY", Gut, 41, 1997, pp. 230-230
26. BAZZOLI F; ZAGARI RM; FESTI D; PALLI D; POZZATO P; SOTTILI S; PANNUCCIO D; JOHRI MA; MWANGEMI C; RICCIARDIELLO L; NICOLINI G; FOSSI S; COLECCHIA A; SIMONI P; RODA A; RODA E
    A POPULATION-BASED STUDY OF HELICOBACTER-PYLORI INFECTION .1. PREVALENCE BY C-13-UREA BREATH TEST AND ASSOCIATION WITH SOCIODEMOGRAPHIC FACTORS
    Gut
    
    F. Bazzoli et al., "A POPULATION-BASED STUDY OF HELICOBACTER-PYLORI INFECTION .1. PREVALENCE BY C-13-UREA BREATH TEST AND ASSOCIATION WITH SOCIODEMOGRAPHIC FACTORS", Gut, 41, 1997, pp. 42-42
27. BALDI F; BRANCACCIO ML; CAPPIELLO R; DINELLI M; FEI L; MATTIOLI S; MISSALE G; PASSARETTI S; SABLICH R; SOTTILI S; STANGHELLINI V; VANTINI I
    PROXIMAL G-E REFLUX IN PATIENTS WITH UNEXPLAINED OTOLARYNGOLOGIC (ORL) SYMPTOMS - A MULTICENTER STUDY IN ITALY
    Gastroenterology
    
    F. Baldi et al., "PROXIMAL G-E REFLUX IN PATIENTS WITH UNEXPLAINED OTOLARYNGOLOGIC (ORL) SYMPTOMS - A MULTICENTER STUDY IN ITALY", Gastroenterology, 112(4), 1997, pp. 63-63
28. BAZZOLI F; ZAGARI RM; FESTI D; PALLI D; POZZATO P; SOTTILI S; PANNUCCIO D; JOHRI MA; MWANGEMI C; RICCIARDIELLO L; NICOLINI G; FOSSI S; COLECCHIA A; SIMONI P; RODA A; RODA E
    A POPULATION-BASED STUDY OF HELICOBACTER-PYLORI INFECTION .1. PREVALENCE BY C-13-UREA BREATH TEST AND ASSOCIATION WITH SOCIODEMOGRAPHIC FACTORS
    Gastroenterology
    
    F. Bazzoli et al., "A POPULATION-BASED STUDY OF HELICOBACTER-PYLORI INFECTION .1. PREVALENCE BY C-13-UREA BREATH TEST AND ASSOCIATION WITH SOCIODEMOGRAPHIC FACTORS", Gastroenterology, 112(4), 1997, pp. 68-68
29. BAZZOLI F; ZAGARI RM; FESTI D; PALLI D; POZZATO P; SOTTILI S; PANNUCCIO D; JOHRI MA; MWANGEMI C; RICCIARDIELLO L; NICOLINI G; FOSSI S; COLECCHIA A; SIMONI P; RODA A; RODA E
    A POPULATION-BASED STUDY OF HELICOBACTER-PYLORI INFECTION .3. PREVALENCE BY C-13-UREA BREATH TEST AND ASSOCIATION WITH DYSPEPTIC SYMPTOMS
    Gastroenterology
    
    F. Bazzoli et al., "A POPULATION-BASED STUDY OF HELICOBACTER-PYLORI INFECTION .3. PREVALENCE BY C-13-UREA BREATH TEST AND ASSOCIATION WITH DYSPEPTIC SYMPTOMS", Gastroenterology, 112(4), 1997, pp. 68-68
30. BAZZOLI F; ZAGARI RM; FESTI D; PALLI D; POZZATO P; SOTTILI S; PANNUCCIO D; JOHRI MA; MWANGEMI C; RICCIARDIELLO L; NICOLINI G; FOSSI S; CORTESE N; SIMONI P; RODA A; RODA E
    A POPULATION-BASED STUDY OF HELICOBACTER-PYLORI INFECTION .2. PREVALENCE BY C-13-UREA BREATH TEST AND ASSOCIATION WITH FAMILY HISTORY OF PEPTIC-ULCER AND GASTRIC-CANCER
    Gastroenterology
    
    F. Bazzoli et al., "A POPULATION-BASED STUDY OF HELICOBACTER-PYLORI INFECTION .2. PREVALENCE BY C-13-UREA BREATH TEST AND ASSOCIATION WITH FAMILY HISTORY OF PEPTIC-ULCER AND GASTRIC-CANCER", Gastroenterology, 112(4), 1997, pp. 68-68
31. AZZAROLI F; MAZZELLA G; DEVERGORI E; FESTI D; COLECCHIA A; VILLANOVA N; SIMONI P; MAZZEO C; SOTTILI S; RODA E
    SLUGGISH GALLBLADDER AND SMALL-BOWEL MOTILITY ARE ASSOCIATED WITH CHOLESTEROL GALLSTONES
    Gastroenterology
    
    F. Azzaroli et al., "SLUGGISH GALLBLADDER AND SMALL-BOWEL MOTILITY ARE ASSOCIATED WITH CHOLESTEROL GALLSTONES", Gastroenterology, 112(4), 1997, pp. 499-499
32. ACCOGLI E; MAZZELLA G; SOTTILI S; COLECCHIA A; FESTI D; JABOLI F; CIRIACI AM; RODA E
    ALPHA-INTERFERON PREVENTS HEPATOCELLULAR-CARCINOMA IN RESPONDERS WITHHCV-ASSOCIATED HEPATIC CIRRHOSIS
    Gastroenterology
    
    E. Accogli et al., "ALPHA-INTERFERON PREVENTS HEPATOCELLULAR-CARCINOMA IN RESPONDERS WITHHCV-ASSOCIATED HEPATIC CIRRHOSIS", Gastroenterology, 112(4), 1997, pp. 1206-1206
33. MAZZELLA G; ACCOGLI E; SOTTILI S; FESTI D; ORSINI M; SALZETTA A; NOVELLI V; CIPOLLA A; FABBRI C; PEZZOLI A; RODA E
    ALPHA-INTERFERON TREATMENT MAY PREVENT HEPATOCELLULAR-CARCINOMA IN HCV-RELATED LIVER-CIRRHOSIS
    Journal of hepatology
    
    G. Mazzella et al., "ALPHA-INTERFERON TREATMENT MAY PREVENT HEPATOCELLULAR-CARCINOMA IN HCV-RELATED LIVER-CIRRHOSIS", Journal of hepatology, 24(2), 1996, pp. 141-147
34. ARIENTI V; CALIFANO C; BRUSCO G; BORIANI L; BIAGI F; SAMA MG; SOTTILI S; DOMANICO A; CORAZZA GR; GASBARRINI G
    DOPPLER ULTRASONOGRAPHIC EVALUATION OF SPLANCHNIC BLOOD-FLOW IN CELIAC-DISEASE
    Gut
    
    V. Arienti et al., "DOPPLER ULTRASONOGRAPHIC EVALUATION OF SPLANCHNIC BLOOD-FLOW IN CELIAC-DISEASE", Gut, 39(3), 1996, pp. 369-373
35. BAZZOLI F; CECCHINI L; CORVAGLIA L; ANTONIA MD; LIBERA MD; DEGIACOMO C; FOSSI S; GARISIO P; CASALI LG; GULLINI S; LAZZARI R; LEGGERI G; LERRO P; LIZZOLI F; MANDRIOLI G; MARANI M; MARTELLI P; MIANO A; MWANGEMI C; ODERDA G; PASETTI A; PAZZI P; POZZATO P; RICCIARDIELLO L; RODA E; SIMONI P; SOTTILI S; TORRE G; URSO L; ZAGARI RM
    THE C-13-UREA BREATH TEST FOR THE DIAGNOSIS OF HELICOBACTER-PYLORI INFECTION IN CHILDREN
    Gastroenterology
    
    F. Bazzoli et al., "THE C-13-UREA BREATH TEST FOR THE DIAGNOSIS OF HELICOBACTER-PYLORI INFECTION IN CHILDREN", Gastroenterology, 110(4), 1996, pp. 60-60
36. BAZZOLI F; ZAGARI RM; FOSSI S; POZZATO P; ALAMPI G; SOTTILI S; SIMONI P; MWANGEMI C; RICCIARDIELLO L; RODA A; RODA E
    SHORT-TERM LOW-DOSE TRIPLE THERAPY FOR THE ERADICATION OF HELICOBACTER-PYLORI - A RANDOMIZED, DOUBLE-BLIND, CONTROLLED-STUDY
    Gastroenterology
    
    F. Bazzoli et al., "SHORT-TERM LOW-DOSE TRIPLE THERAPY FOR THE ERADICATION OF HELICOBACTER-PYLORI - A RANDOMIZED, DOUBLE-BLIND, CONTROLLED-STUDY", Gastroenterology, 110(4), 1996, pp. 61-61
37. PRETOLANI S; ZAGARI RM; BAZZOLI F; POZZATO P; MIGLIO F; FOSSI S; SOTTILI S; FIGURA N; BONVICINI F; BALDINI L; STEFANELLI ML; GHIRONZI GC; RODA E; GASBARRINI G
    CYTOTOXIC HELICOBACTER-PYLORI STRAINS AND UREASE ACTIVITY IN A POPULATION AT HIGH GASTRIC-CANCER RISK
    Gastroenterology
    
    S. Pretolani et al., "CYTOTOXIC HELICOBACTER-PYLORI STRAINS AND UREASE ACTIVITY IN A POPULATION AT HIGH GASTRIC-CANCER RISK", Gastroenterology, 110(4), 1996, pp. 234-234
38. ARIENTI V; CALIFANO C; BRUSCO G; BORIANI L; BIAGI F; SAMA MG; DOMANICO A; SOTTILI S; CORAZZA GR; GASBARRINI G
    DOPPLER ULTRASONOGRAPHIC (US) EVALUATION OF SPLANCHNIC BLOOD-FLOW IN CELIAC-DISEASE
    Gastroenterology
    
    V. Arienti et al., "DOPPLER ULTRASONOGRAPHIC (US) EVALUATION OF SPLANCHNIC BLOOD-FLOW IN CELIAC-DISEASE", Gastroenterology, 110(4), 1996, pp. 310-310
39. BAZZOLI F; FOSSI S; ZAGARI RM; SOTTILI S; RICCIARDIELLO L; POZZATO P; MWANGEMI C; RODA E
    INCIDENCE AND RECURRENCE RATES OF COLORECTAL ADENOMAS IN FIRST-DEGREERELATIVES OF COLON-CANCER PATIENTS
    Gastroenterology
    
    F. Bazzoli et al., "INCIDENCE AND RECURRENCE RATES OF COLORECTAL ADENOMAS IN FIRST-DEGREERELATIVES OF COLON-CANCER PATIENTS", Gastroenterology, 110(4), 1996, pp. 490-490
40. FESTI D; ORSINI M; COLECCHIA A; SOTTILI S; SANGERMANO A; MAZZELLA G; VILLANOVA N; PETRONI ML; PAVESI S; RODA E
    GALLBLADDER MOTILITY AND GALLSTONE FORMATION DURING RAPID WEIGHT-LOSSINDUCED BY VERY-LOW-CALORIE DIETS - A PRESENT CONFIRMATION OF AN OLD CLINICAL OBSERVATION
    Gastroenterology
    
    D. Festi et al., "GALLBLADDER MOTILITY AND GALLSTONE FORMATION DURING RAPID WEIGHT-LOSSINDUCED BY VERY-LOW-CALORIE DIETS - A PRESENT CONFIRMATION OF AN OLD CLINICAL OBSERVATION", Gastroenterology, 110(4), 1996, pp. 663-663
41. MAZZELLA G; NOVELLI V; CIRIACI AM; CIPOLLA A; MARCHETTO S; SOTTILI S; RODA E
    PREDICTIVE FACTORS OF RESPONSE IN ALPHA-INTERFERON TREATED HEPATITIS-C - RESULTS AFTER 2 YEARS OF FOLLOW-UP
    Gastroenterology
    
    G. Mazzella et al., "PREDICTIVE FACTORS OF RESPONSE IN ALPHA-INTERFERON TREATED HEPATITIS-C - RESULTS AFTER 2 YEARS OF FOLLOW-UP", Gastroenterology, 110(4), 1996, pp. 1263-1263
42. MAZZELLA G; SARACCO G; MARCHETTO S; ROSINA F; CIPOLLA A; JABOLI F; VERME G; MINIERO R; CANCELLIERI C; FESTI D; SOTTILI S; RODA E; RIZZETTO M
    LONG-TERM OUTCOME OF INTERFERON THERAPY IN CHRONIC TYPE-B HEPATITIS -IS NATURAL-HISTORY MODIFIED
    Gastroenterology
    
    G. Mazzella et al., "LONG-TERM OUTCOME OF INTERFERON THERAPY IN CHRONIC TYPE-B HEPATITIS -IS NATURAL-HISTORY MODIFIED", Gastroenterology, 110(4), 1996, pp. 1263-1263
43. VILLANOVA N; FESTI D; SOTTILI S; GEMINIANI S; PUCCETTI AL; ORSINI M; SANGERMANO A; MAZZELLA G; CORNIA GL; RODA E
    WEIGHT CYCLING DIETING AND GALLSTONES IN FEMALE OBESE PATIENTS
    Gastroenterology
    
    N. Villanova et al., "WEIGHT CYCLING DIETING AND GALLSTONES IN FEMALE OBESE PATIENTS", Gastroenterology, 110(4), 1996, pp. 1355-1355
44. VILLANOVA N; FESTI D; SOTTILI S; MAZZELLA G; GEMINIANI S; PUCCETTI A; ORSINI M; SANGERMANO A; RODA E
    OBESITY AND GALLSTONES - IS DIETARY BEHAVIOR A RISK FACTOR
    Hepatology
    
    N. Villanova et al., "OBESITY AND GALLSTONES - IS DIETARY BEHAVIOR A RISK FACTOR", Hepatology, 22(4), 1995, pp. 26-26
45. FESTI D; SANGERMANO A; SOTTILI S; COLECCHIA A; ORSINI M; RODA E
    FREQUENCY AND CHARACTERISTICS OF ABDOMINAL SYMPTOMS IN GALLSTONE DISEASE - RESULTS OF AN EPIDEMIOLOGIC-STUDY
    Hepatology
    
    D. Festi et al., "FREQUENCY AND CHARACTERISTICS OF ABDOMINAL SYMPTOMS IN GALLSTONE DISEASE - RESULTS OF AN EPIDEMIOLOGIC-STUDY", Hepatology, 22(4), 1995, pp. 27-27
46. BALDINI N; SCOTLANDI K; BARBANTIBRODANO G; MANARA MC; MAURICI D; BACCI G; BERTONI F; PICCI P; SOTTILI S; CAMPANACCI M; SERRA M
    EXPRESSION OF P-GLYCOPROTEIN IN HIGH-GRADE OSTEOSARCOMAS IN RELATION TO CLINICAL OUTCOME
    The New England journal of medicine
    
    N. Baldini et al., "EXPRESSION OF P-GLYCOPROTEIN IN HIGH-GRADE OSTEOSARCOMAS IN RELATION TO CLINICAL OUTCOME", The New England journal of medicine, 333(21), 1995, pp. 1380-1385
47. BAZZOLI F; FOSSI S; SOTTILI S; POZZATO P; ZAGARI RM; MORELLI MC; TARONI F; RODA E
    THE RISK OF ADENOMATOUS POLYPS IN ASYMPTOMATIC FIRST-DEGREE RELATIVESOF PERSONS WITH COLON-CANCER
    Gastroenterology
    
    F. Bazzoli et al., "THE RISK OF ADENOMATOUS POLYPS IN ASYMPTOMATIC FIRST-DEGREE RELATIVESOF PERSONS WITH COLON-CANCER", Gastroenterology, 109(3), 1995, pp. 783-788
48. FESTI D; SANGERMANO A; SOTTILI S; COLECCHIA A; ORSINI M; RODA E
    ULTRASONOGRAPHIC CHARACTERISTICS OF GALLSTONES AND BILIARY SYMPTOMS -RESULTS OF AN EPIDEMIOLOGIC-STUDY (THE MICOL STUDY)
    Gastroenterology
    
    D. Festi et al., "ULTRASONOGRAPHIC CHARACTERISTICS OF GALLSTONES AND BILIARY SYMPTOMS -RESULTS OF AN EPIDEMIOLOGIC-STUDY (THE MICOL STUDY)", Gastroenterology, 108(4), 1995, pp. 14-14
49. VILLANOVA N; FESTI D; SOTTILI S; MAZZELLA G; GEMIGNANI S; PUCCETTI A; ORSINI M; SANGERMANO A; CORNIA GL; RODA E
    OBESITY AND GALLSTONES - IS DIETARY BEHAVIOR A RISK FACTOR
    Gastroenterology
    
    N. Villanova et al., "OBESITY AND GALLSTONES - IS DIETARY BEHAVIOR A RISK FACTOR", Gastroenterology, 108(4), 1995, pp. 39-39
50. BALDI F; BRANCACCIO ML; SOTTILI S; RODA E
    ACID GASTROESOPHAGEAL REFLUX AND SYMPTOMS - ANALYSIS OF FACTORS INFLUENCING THEIR ASSOCIATION
    Gastroenterology
    
    F. Baldi et al., "ACID GASTROESOPHAGEAL REFLUX AND SYMPTOMS - ANALYSIS OF FACTORS INFLUENCING THEIR ASSOCIATION", Gastroenterology, 108(4), 1995, pp. 51-51
51. BAZZOLL F; GULLINI S; ZAGARI RM; PAZZI P; DALLALIBERA M; POZZATO P; SOTTILI S; FOSSI S; CARLI G; SCAGLIARINI R; SIMONI P; RODA E
    EFFECT OF OMEPRAZOLE AND CLARITHROMYCIN PLUS TINIDAZOLE ON THE ERADICATION OF HELICOBACTER-PYLORI AND THE RECURRENCE OF DUODENAL-ULCER
    Gastroenterology
    
    F. Bazzoll et al., "EFFECT OF OMEPRAZOLE AND CLARITHROMYCIN PLUS TINIDAZOLE ON THE ERADICATION OF HELICOBACTER-PYLORI AND THE RECURRENCE OF DUODENAL-ULCER", Gastroenterology, 108(4), 1995, pp. 57-57
52. SANGERMANO A; SOTTILI S; COLECCHIA A; ORSINI M; FESTI D; RODA E
    THE ROLE OF ULTRASOUND IN PREDICTING NO-VISUALIZATION OF THE GALLBLADDER ON ORAL CHOLECYSTOGRAPHY IN GALLSTONE PATIENTS - OBSERVATION DURING AN EPIDEMIOLOGIC-STUDY (THE MICOL STUDY)
    Gastroenterology
    
    A. Sangermano et al., "THE ROLE OF ULTRASOUND IN PREDICTING NO-VISUALIZATION OF THE GALLBLADDER ON ORAL CHOLECYSTOGRAPHY IN GALLSTONE PATIENTS - OBSERVATION DURING AN EPIDEMIOLOGIC-STUDY (THE MICOL STUDY)", Gastroenterology, 108(4), 1995, pp. 434-434
53. BAZZOLI F; FOSSI S; SOTTILI S; POZZATO P; ZAGARI RM; RODA E
    NEED FOR TOTAL COLONOSCOPY SCREENING IN ASYMPTOMATIC SUBJECTS WITH SIMPLE PRIMARY FAMILY HISTORY OF COLORECTAL-CANCER
    Gastroenterology
    
    F. Bazzoli et al., "NEED FOR TOTAL COLONOSCOPY SCREENING IN ASYMPTOMATIC SUBJECTS WITH SIMPLE PRIMARY FAMILY HISTORY OF COLORECTAL-CANCER", Gastroenterology, 108(4), 1995, pp. 448-448
54. BAZZOLI F; FESTI D; MAZZELLA G; FRABBONI R; ZAGARI RM; FOSSI S; POZZATO P; SOTTILI S; SIMONI P; RODA A; RODA E
    ACQUIRED GALLSTONE OPACIFICATION DURING CHOLELITHOLYTIC TREATMENT WITH CHENODEOSCYHOLIC, URSODEOXYCHOLIC, AND TAUROURSODEOXYCHOLIC ACIDS
    The American journal of gastroenterology
    
    F. Bazzoli et al., "ACQUIRED GALLSTONE OPACIFICATION DURING CHOLELITHOLYTIC TREATMENT WITH CHENODEOSCYHOLIC, URSODEOXYCHOLIC, AND TAUROURSODEOXYCHOLIC ACIDS", The American journal of gastroenterology, 90(6), 1995, pp. 978-981
55. BAZZOLI F; ZAGARI RM; FOSSI S; POZZATO P; ALAMPI G; SIMONI P; SOTTILI S; RODA A; RODA E
    SHORT-TERM LOW-DOSE TRIPLE THERAPY FOR THE ERADICATION OF HELICOBACTER-PYLORI
    European journal of gastroenterology & hepatology
    
    F. Bazzoli et al., "SHORT-TERM LOW-DOSE TRIPLE THERAPY FOR THE ERADICATION OF HELICOBACTER-PYLORI", European journal of gastroenterology & hepatology, 6(9), 1994, pp. 773-777
56. BAZZOLI F; ZAGARI RM; FOSSI S; POZZATO P; FESTI D; MAZZELLA G; SOTTILI S; RODA E
    GALLSTONE RECURRENCE AND HISTORY OF SPECIFIC BILIARY SYMPTOMS DURING A LONG-TERM POSTDISSOLUTION FOLLOW-UP
    Hepatology
    
    F. Bazzoli et al., "GALLSTONE RECURRENCE AND HISTORY OF SPECIFIC BILIARY SYMPTOMS DURING A LONG-TERM POSTDISSOLUTION FOLLOW-UP", Hepatology, 19(4), 1994, pp. 90000041-90000041
57. ARIENTI V; CORAZZA GR; SORGE M; BORIANI L; UGENTI F; BIAGI F; MACONI G; SOTTILI S; VANTHIEL DH; GASBARRINI G
    THE EFFECTS OF LEVOSULPIRIDE ON GASTRIC AND GALLBLADDER EMPTYING IN FUNCTIONAL DYSPEPSIA
    Alimentary pharmacology & therapeutics
    
    V. Arienti et al., "THE EFFECTS OF LEVOSULPIRIDE ON GASTRIC AND GALLBLADDER EMPTYING IN FUNCTIONAL DYSPEPSIA", Alimentary pharmacology & therapeutics, 8(6), 1994, pp. 631-638
58. MAZZELLA G; SALZETTA A; CASANOVA S; MORELLI MC; VILLANOVA N; MINIERO R; SOTTILI S; NOVELLI V; CIPOLLA A; FESTI D; RODA E
    TREATMENT OF CHRONIC SPORADIC-TYPE NON-A, NON-B-HEPATITIS WITH LYMPHOBLASTOID INTERFERON - GAMMA-GT LEVELS PREDICTIVE FOR RESPONSE
    Digestive diseases and sciences
    
    G. Mazzella et al., "TREATMENT OF CHRONIC SPORADIC-TYPE NON-A, NON-B-HEPATITIS WITH LYMPHOBLASTOID INTERFERON - GAMMA-GT LEVELS PREDICTIVE FOR RESPONSE", Digestive diseases and sciences, 39(4), 1994, pp. 866-870
59. BAZZOLI F; ZAGARI RM; POZZATO P; FOSSI S; ALAMPI G; SOTTILI S; SIMONI P; RODA A; RODA E
    C-13-UREA BREATH TEST TO QUANTIFY HELICOBACTER-PYLORI COLONIZATION OFGASTRIC-MUCOSA AND ASSOCIATION WITH SEVERITY OF INFLAMMATION
    Gastroenterology
    
    F. Bazzoli et al., "C-13-UREA BREATH TEST TO QUANTIFY HELICOBACTER-PYLORI COLONIZATION OFGASTRIC-MUCOSA AND ASSOCIATION WITH SEVERITY OF INFLAMMATION", Gastroenterology, 106(4), 1994, pp. 10000048-10000048
60. BAZZOLI F; FOSSI S; SOTTILI S; POZZATO P; ZAGARI RM; SIMONI P; RODA A; RODA E
    INCREASED FAMILIAL TENDENCY FOR METACHRONOUS ADENOMATOUS POLYPS IN 1ST DEGREE RELATIVES OF COLON-CANCER PATIENTS
    Gastroenterology
    
    F. Bazzoli et al., "INCREASED FAMILIAL TENDENCY FOR METACHRONOUS ADENOMATOUS POLYPS IN 1ST DEGREE RELATIVES OF COLON-CANCER PATIENTS", Gastroenterology, 106(4), 1994, pp. 10000370-10000370
61. MAZZELLA G; CIPOLLA A; NOVELLI V; FABBI C; FUSAROLI P; SOTTILI S; SALZETTA A; RODA E
    CAN UDCA INCREASE RESPONSE TO INTERFERON IN CHRONIC HEPATITIS-C
    Gastroenterology
    
    G. Mazzella et al., "CAN UDCA INCREASE RESPONSE TO INTERFERON IN CHRONIC HEPATITIS-C", Gastroenterology, 106(4), 1994, pp. 10000941-10000941
62. SOTTILI S; PIZZI A; LOCATELLI C; ABBONDATI G
    TRICHLORETHYLENE IS RADIO-OPAQUE
    Journal of toxicology. Clinical toxicology
    
    S. Sottili et al., "TRICHLORETHYLENE IS RADIO-OPAQUE", Journal of toxicology. Clinical toxicology, 31(4), 1993, pp. 657-661
63. FESTI D; MAZZELLA G; ORSINI M; SOTTILI S; SANGERMANO A; BASSI SL; PARINI P; FERRIERI A; FALCUCCI M; GROSSI L; MARZIO L; RODA E
    RIFAXIMIN IN THE TREATMENT OF CHRONIC HEPATIC-ENCEPHALOPATHY - RESULTS OF A MULTICENTER STUDY OF EFFICACY AND SAFETY
    Current therapeutic research
    
    D. Festi et al., "RIFAXIMIN IN THE TREATMENT OF CHRONIC HEPATIC-ENCEPHALOPATHY - RESULTS OF A MULTICENTER STUDY OF EFFICACY AND SAFETY", Current therapeutic research, 54(5), 1993, pp. 598-609